Origin Agritech collaborates with BRI for GMO Soybean research

To intensify further research in GMO Soybean Development

Beijing-based Origin Agritech Ltd. an agriculture technology company has entered into a collaboration agreement with Biotechnology Research Institute (BRI), a division of Chinese Academy of Agriculture Sciences (CAAS) to jointly collaborate in GMO soybean research and commercialization. 

BRI already has its inhouse developed glyphosate tolerant G2-epsps gene, while Origin owns global exclusive commercial rights in corn, soybean, and other major crops.

Origin and BRI will jointly develop dicamba tolerant, drought tolerant, and salt-alkaline tolerant GMO soybean varieties by using three BRI’s newly developed and patented genes.

Utilizing the G2-epsps gene, BRI had developed GMO glyphosate tolerant soybean, which bagged the bio-safety certificate on July 15, 2020. The new collaboration will focus on related research and commercialization of GMO soybean.

BRI will focus on fundamental research and provide technical support to Origin on GMO soybean product development and global commercialization